The Next Generation Longitudinal Birth Cohort Diabetes Study

Last updated: June 5, 2024
Sponsor: University of Manitoba
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Diabetes Mellitus Types I And Ii

Treatment

Observational screening study

Clinical Study ID

NCT04621396
H2013:227
  • Ages < 18
  • All Genders

Study Summary

The overall aim of this project is to understand the independent roles of maternal factors, intrauterine exposures, genetic factors, and postnatal environment on the development of obesity and youth-onset type 2 diabetes (T2D) in childhood.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pregnant women with type 2 diabetes, gestational diabetes, or no diabetes.

  • From self-identified Indigenous heritage (e.g., Cree, Oji-Cree, Métis, Anishinaabe,etc.).

  • Are delivering and residing in Manitoba.

  • Mother/Father and children must be biological family members.

Exclusion

Exclusion Criteria:

  • Mothers or children with type 1 diabetes.

  • Residing outside of Manitoba.

Study Design

Total Participants: 600
Treatment Group(s): 1
Primary Treatment: Observational screening study
Phase:
Study Start date:
September 01, 2013
Estimated Completion Date:
December 31, 2028

Study Description

Our primary objective for the study is to clinically and metabolically phenotype parents and their offspring to identify risk factors for obesity, T2D, and cardiometabolic risk in childhood and adolescence in a prospective birth cohort by reporting:

  1. Maternal and/or paternal factors including anthropometrics, metabolic parameters, HNF1a genotype, lifestyle (diet and physical activity), and socioeconomic environment.

  2. Infant factors including anthropometrics, early infant nutrition, and metabolism.

Secondary Objectives:

  1. To evaluate if children born to mothers with T2D prior o pregnancy are at increased risk of obesity and T2D.

  2. To determine the modifiable risk factors which contribute to the increased risk of obesity and T2D.

  3. To evaluate the differential risk between mothers and fathers with T2D in terms of somatic and genetic contributions to risk compared to intrauterine environmental contributions to risk.

  4. To plan a large-scale, randomized, controlled community-based breastfeeding intervention with intensive breastfeeding counseling and support for the prevention of T2D development in offspring of mothers or fathers with youth onset T2D.

  5. To explore potential new research questions and feasibility studies for epigenetic studies using cord blood under the umbrella of the new research theme on T2D at the Children's Hospital Research Institute of Manitoba.

Connect with a study center

  • Children's Hospital Research Institute of Manitoba/University of Manitoba

    Winnipeg, Manitoba R3E 3P4
    Canada

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.